T1	Participants 684 723	older populations at risk of depression
T2	Participants 740 828	Subjects with previously reported sub-threshold depressive symptoms, aged 60 to 74 years
T3	Participants 1057 1412	Subjects will be excluded if they have current depression or suicide ideation; are taking antidepressants or any supplement containing omega-3 fatty acid; or have a prior history of stroke or other serious cerebrovascular or cardiovascular disease, neurological disease, significant psychiatric disease (other than depression) or neurodegenerative disease
T4	Participants 1829 1949	The trial will be conducted in urban New South Wales, Australia, and will recruit a community-based sample of 450 adults
T5	Participants 2396 2408	older adults
